Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer
Massimiliano Salati et al.
LIVER INTERNATIONAL (2020)
Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancer
Mohamed Mady et al.
HPB (2020)
Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
Chiao-En Wu et al.
BMC CANCER (2020)
Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location
Byeong Geun Song et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Modified gemcitabine and oxaliplatin or gemcitabine plus cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial
Atul Sharma et al.
EUROPEAN JOURNAL OF CANCER (2019)
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Yuko Suzuki et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Gallbladder cancer: epidemiology and genetic risk associations
Mikayla A. Schmidt et al.
CHINESE CLINICAL ONCOLOGY (2019)
Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial
Gaelle Vanbutsele et al.
LANCET ONCOLOGY (2018)
Gemcitabine-based chemotherapy for advanced biliary tract carcinomas
Omar Abdel-Rahman et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis
Haowen Tang et al.
ONCOTARGET (2017)
Early palliative care for adults with advanced cancer
Markus W. Haun et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
J. Bridgewater et al.
ANNALS OF ONCOLOGY (2016)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma
Nestor F. Esnaola et al.
CANCER (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies
T. Grenader et al.
ANNALS OF ONCOLOGY (2015)
Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer
M. G. McNamara et al.
EUROPEAN JOURNAL OF CANCER (2014)
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
David Malka et al.
LANCET ONCOLOGY (2014)
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
Frederic Fiteni et al.
CANCER MEDICINE (2014)
Treatment decisions and discontinuation of palliative chemotherapy near the end-of-life, in relation to socioeconomic variables
Margareta Randen et al.
ACTA ONCOLOGICA (2013)
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2012)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prognostic Factors and Predictive Model in Patients With Advanced Biliary Tract Adenocarcinoma Receiving First-Line Palliative Chemotherapy
Inkeun Park et al.
CANCER (2009)
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study
T. Andre et al.
BRITISH JOURNAL OF CANCER (2008)
Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
Michelle L. DeOliveira et al.
ANNALS OF SURGERY (2007)
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma:: a GERCOR study
T André et al.
ANNALS OF ONCOLOGY (2004)
A phase II study of gemcitabine in gallbladder carcinoma
JO Gallardo et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
